Document is current
Any future updates will be listed below
-
Authors
Bernal, Jose
Menze, Inga
Yakupov, Renat
Peters, Oliver
Hellmann-Regen, Julian
Freiesleben, Silka Dawn
Priller, Josef
Spruth, Eike Jakob
Altenstein, Slawek
Schneider, Anja
Fliessbach, Klaus
Wiltfang, Jens
Schott, Björn H.
Jessen, Frank
Rostamzadeh, Ayda
Glanz, Wenzel
Incesoy, Enise I.
Buerger, Katharina
Janowitz, Daniel
Ewers, Michael
Perneczky, Robert
Rauchmann, Boris-Stephan
Teipel, Stefan
Kilimann, Ingo
Laske, Christoph
Sodenkamp, Sebastian
Spottke, Annika
Esser, Anna
Lüsebrink, Falk
Dechent, Peter
Hetzer, Stefan
Scheffler, Klaus
Schreiber, Stefanie
Düzel, Emrah
Ziegler, Gabriel
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (CRC 1436, projects A05, B02, B04 and C01, CRC 1436, projects A05, B02, B04 and C01)
Deutsches Zentrum für Neurodegenerative Erkrankungen (BN012, BN012)
Otto-von-Guericke-Universität Magdeburg
- License Information
-
More Information
Article History
Received: 10 July 2024
Accepted: 18 October 2024
First Online: 28 October 2024
Declarations
:
: The study protocol was approved by the ethical committees of the medical faculties of all participating sites: the ethical committees of Berlin (Charite, University Medicine), Bonn, Cologne, Goettingen, Magdeburg, Munich (Ludwig-Maximilians-University), Rostock, and Tuebingen. The process was led and coordinated by the ethical committee of the medical faculty of the University of Bonn. All commitees gave ethical approval for this work. All participants provided their written informed consent before inclusion in the study. DELCODE is retrospectively registered at the German Clinical Trials Register (DRKS00007966, 04/05/2015). The DELCODE study was conducted in accordance with the Declaration of Helsinki.
: Not applicable.
: The authors declare no competing interests.
